Regulatory Text: 
Oklahoma Administrative Code.  Title 252.  Department of Environmental Quality 

Chapter 100.  Air Pollution Control (OAC 252:100)

SUBCHAPTER 17.  INCINERATORS

PART 4. BIOMEDICAL WASTE INCINERATORS, SIP effective January 4, 2016 (OKd15).
Adopted in Oklahoma Register May 2, 2011 (28 Ok Reg 643) effective July 1, 2011,
Submitted to EPA January 18, 2013 (OK-46),
Regulations.gov document EPA-R06-OAR-2011-0034-0008 [OK017.08] page 317-318.
Approved by EPA November 3, 2015 (80 FR 67647) effective January 4, 2016 (OKd15), 
Regulations.gov docket EPA-R06-OAR-2011-0034 [OK017].

Outline:
252:100-17-8.    Applicability, OKd15
252:100-17-9.    Definitions, OKd15
252:100-17-10.   Design and operation, OKd15
252:100-17-11.   Emission limits, OKd15

252:100-17-8.  Applicability
     This part applies to any new or existing biomedical waste
incinerator that is not subject to the requirements of Part 7 of
this subchapter or is exempted from the requirements of 
Subpart Ec of 40 CFR Part 60.

252:100-17-9.  Definitions
     The following words and terms when used in this part shall
have the following meaning unless the context clearly indicates
otherwise:
     "Antineoplastic agents" means drugs used to inhibit and
combat the development of neoplasms.
     "Biomedical radioactive waste" means low-level radioactive
waste as defined in 40 CFR 60.51c.
     "Biomedical waste" means medical/infectious waste
as defined in 40 CFR 60.51c, Chemotherapeutic waste and
biomedical radioactive waste.
     "Biomedical waste incinerator" means an incinerator
used to burn biomedical waste.
     "Chemotherapeutic waste" means waste material resulting
from the production or use of antineoplastic agents.
     "Neoplasms" means tumors consisting of an abnormal
proliferation of cells.  The growth of this clone of cells exceeds,
and is uncoordinated with, that of the normal tissues around it.
Neoplasms may be benign, pre-malignant or malignant.

252:100-17-10.  Design and operation
     An incinerator subject to this part shall be designed and
built with a primary combustion chamber and secondary combustion
chamber(s) each equipped with burners or other combustion
devices that maintain the applicable temperature and
retention time specified in (1) through (3) of this section in
both the primary and secondary combustion chamber(s) at all
times when biomedical waste is being incinerated.
     (1)  The temperature in the primary combustion chamber 
shall not be less than 1,200 degrees F.
     (2)  The temperature in the secondary combustion 
chamber(s) shall not be less than 1,800 degrees F with a retention 
time of not less than one (1) second when processing 
biomedical waste containing no chemotherapeutic waste.
     (3)  The temperature in the secondary combustion 
chamber(s) shall not be less than 2,000 degrees F with a retention 
time of not less than two (2) seconds when processing 
biomedical waste containing chemotherapeutic waste.

252:100-17-11.  Emission limits
     Emissions from any biomedical waste incinerator subject 
to the requirements of this part shall not exceed the limits specified 
in (1) through (3) of this section.  Any required performance 
testing shall be conducted while the incinerator is operating 
between 90% and 100% of operating capacity, or under 
other representative operating conditions specified by an applicable 
permit or testing method.
     (1)  Hydrochloric acid (HCl).  Emissions of HCl shall
not exceed 4.0 lb/hr.
     (2)  Particulate matter.  Emissions of particulate matter 
shall not exceed 0.08 gr/dscf (grains per dry standard 
cubic foot) corrected to12% carbon dioxide in the emission gas stream.
     (3)  Carbon monoxide (CO).  Emissions of CO shall 
not exceed 100 ppm by volume corrected to standard 
conditions in the emission gas stream.

***End 252:100-17 Part 4 SIP effective January 4,  2016***OKd15***OK017***z9a***